For example, a variety of inflammatory factors, including IL-6 and ROS, along with the abnormal activation of immune cells, collectively create a pro-cancer “inflammatory microenvironment.” Therefore, reducing and regulating the level of inflammation within the tumor microenvironment has become one of the key strategies in cancer treatment. Here, IL6 is linked to cancer.